CONTACTStaffCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
The Washington Post on Wednesday profiled the Nigerian arm of an ongoing clinical trial that is testing the antiretroviral drug Viread--which is known generically as tenofovir--to determine if it can reduce the risk of HIV infection. Researchers in the city of Ibadan have enrolled approximately 125 commercial sex workers, who were recruited from several brothels and have been taking the drug once a day since July. The National Institutes of Health, Centers for Disease Control and Prevention, and the Bill and Melinda Gates Foundation are funding three separate studies of Viread, which is manufactured by Gilead Sciences. The drug is FDA-approved for use as a treatment for HIV infection and has been shown to boost immune response and lower viral levels in the bloodstreams of patients who are resistant to other antiretrovirals. The CDC has granted $3.5 million to fund trial sites in San Francisco and Atlanta, while the Gates Foundation awarded a $6.5 million grant to Family Health International to conduct a randomized, placebo-controlled clinical trial including 2,000 HIV-negative volunteers at sites in Cambodia, Ghana, Cameroon, Nigeria, and Malawi. According to a report by the Kaiser Family Foundation, the NIH also awarded a $2.1 million grant to University of California, San Francisco, researchers to test Viread in 960 HIV-negative Cambodian women, most of whom are commercial sex workers. However, Cambodian prime minister Hun Sen in August ordered a stop to the planned human clinical trial in the country because of the possible effects of the drug on trial participants. The initial results of the Nigerian study are expected in 2006, according to the Post.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Here Are Our 2024 Election Predictions. Will They Come True?
November 07 2023 1:46 PM
17 Celebs Who Are Out & Proud of Their Trans & Nonbinary Kids
November 30 2023 10:41 AM
Here Are the 15 Most LGBTQ-Friendly Cities in the U.S.
November 01 2023 5:09 PM
Which State Is the Queerest? These Are the States With the Most LGBTQ+ People
December 11 2023 10:00 AM
These 27 Senate Hearing Room Gay Sex Jokes Are Truly Exquisite
December 17 2023 3:33 PM
30 Steamy Photos of Folsom Street Fair 2023 Debauchery
October 15 2023 11:06 PM
10 Cheeky and Homoerotic Photos From Bob Mizer's Nude Films
November 18 2023 10:05 PM
42 Flaming Hot Photos From 2024's Australian Firefighters Calendar
November 10 2023 6:08 PM
These Are the 5 States With the Smallest Percentage of LGBTQ+ People
December 13 2023 9:15 AM
Here are the 15 gayest travel destinations in the world: report
March 26 2024 9:23 AM
Watch Now: Advocate Channel
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Latest Stories
The North Face faces conservative boycott for sponsoring a queer summer camp (exclusive)
April 10 2024 8:26 AM
John Cena opens up about defending his gay brother when they were kids
April 09 2024 10:21 PM
Trans Latina Meraxes Medina killed in Los Angeles
April 09 2024 10:11 PM
Morgxn is proudly queering Southern music - here's how
April 09 2024 7:03 PM
Elon Musk uses burner accounts on X, doesn’t fact-check: report
April 09 2024 5:44 PM
Pride
Yahoo FeedDiscover endless fun at The Pride Store: Games & electronics for all ages
April 09 2024 4:25 PM
Mean Girls' Daniel Franzese on playing an HIV+ character
April 09 2024 4:19 PM